What is RAD140?
RAD140 is named after Radius Health, Inc. (RDUS) whose internal nonsteroidal selective androgen receptor modulator (“SARM”) program discovered it. It is being studied as a potential therapy for the treatment of age-related muscle loss (sarcopenia) and other musculoskeletal conditions such as osteoporosis. Radius selected RAD140 from a series of promising SARMs after it demonstrated exceptional selectivity for anabolic activity in well-validated in vivo models. It has demonstrated a greater anabolic activity than testosterone.
(For more information please see our blog disclaimer.)